Skip to Content
You are currently on the new version of our website. Access the old version .

Future Pharmacology, Volume 5, Issue 2

2025 June - 17 articles

Cover Story:

The pharmaceutical industry faces growing pressure to reduce its environmental impact, including a carbon footprint estimated to be 55% higher than that of the automotive industry. Artificial intelligence has emerged as a transformative tool that helps achieve greener pharmaceutical practices throughout the entire drug life cycle. AI-driven models are being explored to personalise dosing, minimise pharmaceutical waste, and speed up the discovery of new, biodegradable drugs. AI is also being used to improve the synthesis of active pharmaceutical compounds by designing new catalysts, enzymes, and solvents. Despite these advances, progress is constrained by limitations such as small datasets, computationally intensive models, and a lack of standardised life cycle assessments that quantify the true environmental benefits of these technologies. View this paper

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (17)

  • Review
  • Open Access
2 Citations
3,485 Views
21 Pages

Osteoarthritis (OA) is a multifactorial, degenerative joint disease that significantly impairs mobility and quality of life, especially among older adults. The growing aging population and increasing obesity rates are expected to increase the inciden...

  • Review
  • Open Access
3 Citations
3,033 Views
18 Pages

Algal polysaccharides are a kind of bioactive compound with diverse pharmacological applications, yet their structure–activity relationships and therapeutic potential in chronic disease management remain systematically underexplored. This revie...

  • Review
  • Open Access
1,246 Views
13 Pages

On the Molecular Origin of the Toxicity of Erophaca baetica (L.) Boiss.

  • Mounia Chroho,
  • Latifa Bouissane and
  • Christian Bailly

Background/Objectives: The plant species Erophaca baetica (L.) Boiss. (synonym: Astragalus lusitanicus Lam.) is found essentially around the Mediterranean basin, with Morocco as its ancestral territory. The foliage of E. baetica is toxic to small rum...

  • Article
  • Open Access
3,575 Views
14 Pages

Recovery from AMPA Receptor Potentiation by Ampakines

  • Daniel P. Radin,
  • Rok Cerne,
  • Jodi L. Smith,
  • Jeffrey M. Witkin and
  • Arnold Lippa

Background: Ampakines are a family of molecules that enhance the functioning of AMPA-glutamate receptors (AMPAR). High-impact ampakines completely offset receptor desensitization and enhance agonist binding affinity, while low-impact ampakines only m...

  • Article
  • Open Access
1 Citations
1,766 Views
19 Pages

Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs

  • Bradley S. Wahle,
  • Peter Pushko,
  • Katie Albanese,
  • Dylan M. Johnson,
  • Irina Tretyakova,
  • Igor S. Lukashevich and
  • Thomas Rudge

(1) Background: Mopeia–Lassa reassortant ML29 virus is an investigational, reassortant virus vaccine for the prevention of Lassa fever caused by Lassa virus (LASV). (2) Methods: The vaccine virus ML29-SF was prepared in Vero cells using a serum...

  • Article
  • Open Access
2,404 Views
13 Pages

KRM-II-81, a β3-Preferring GABAA Receptor Potentiator, Blocks Handling-Induced Seizures in Theiler’s Murine Encephalomyelitis Virus-Infected Mice

  • Dishary Sharmin,
  • Kamal P. Pandey,
  • Lalit K. Golani,
  • Sepideh Rezvanian,
  • Md Yeunus Mian,
  • Janet L. Fisher,
  • Arnold Lippa,
  • James M. Cook,
  • Daniel P. Radin and
  • Rok Cerne
  • + 3 authors

Background: The GABAA receptor (GABAAR) potentiator, KRM-II-81, is being developed as a novel antiseizure medication with reduced potential for sedation, tolerance development, and abuse liability. Although KRM-II-81 has been shown to provide antisei...

  • Review
  • Open Access
10 Citations
4,682 Views
25 Pages

The pharmaceutical industry faces mounting pressure to reduce its environmental impact while maintaining innovation in drug development. Artificial intelligence (AI) has emerged as a transformative tool across healthcare and drug discovery, yet its p...

  • Article
  • Open Access
2 Citations
1,731 Views
13 Pages

Antimicrobial Activity of N-Methyl 4-Piperidone-Derived Monoketone Curcuminoids Against Cariogenic Bacteria

  • Richard H. Lima,
  • Yan R. Robles,
  • Isabelle M. Oliva,
  • Anna L. O. Santos,
  • Júlia G. Teixeira,
  • Maria A. S. C. Chellegatti,
  • Niege A. J. C. Furtado,
  • Carlos H. G. Martins,
  • Viviani Nardini and
  • Antônio E. M. Crotti

Background/Objectives: Dental caries and candidiasis are major health problems worldwide. Dental caries is caused by cariogenic bacteria, especially those belonging to the Streptococcus genus, whereas candidiasis is caused by Candida species. In this...

  • Article
  • Open Access
1,262 Views
17 Pages

Effects of Polydatin on Pentylenetetrazol-Induced Seizures in Zebrafish Larvae

  • Fernanda Barros de Miranda,
  • Lucia Emanueli Schimith,
  • Dennis Guilherme da Costa Silva,
  • Camila de Oliveira Vian,
  • Diele Bopsin da Luz,
  • Rafael Felipe de Aguiar,
  • Crístian Yan Montana da Rocha,
  • Anna Maria Siebel,
  • Jean Pierre Oses and
  • Mariana Appel Hort

Background/Objectives: Epilepsy is a common neurological condition characterized by the occurrence of a seizure. It affects around 50 million individuals worldwide, and despite the large quantity of anti-seizure medications available, 30% of epilepti...

  • Systematic Review
  • Open Access
2 Citations
1,598 Views
23 Pages

Background/Objectives: Limitations of conventional treatments for esophageal cancer, which include poor solubility, drug resistance, and undesirable side effects, make it imperative to explore new therapeutic approaches to slow the progression of thi...

  • Review
  • Open Access
9,313 Views
20 Pages

Can Drug-Induced Yawning Serve as a Biomarker for Drug Safety and Effectiveness?

  • Mohammad Rokan Ali,
  • Khaled Alzaeem,
  • Mostafa Bejermie,
  • Cole Ngwachi Mangong Fofang,
  • Siamand Mohamad and
  • Parisa Gazerani

Background/Objectives: Yawning, a common physiological behavior, has emerged as a potential biomarker for drug responsiveness and side effects. This scoping review synthesizes current evidence on drug-induced yawning (DIY), focusing on its neurobiolo...

  • Article
  • Open Access
1,049 Views
11 Pages

An In Vitro Diacetylcurcumin Study for Periodontitis: A New Approach to Controlling Subgingival Biofilms

  • Valdo Antonio Aires da Silva,
  • Bruno Bueno-Silva,
  • Luciene Cristina Figueiredo,
  • Tatiane Tiemi Macedo,
  • Lucas Daylor Aguiar da Silva,
  • Helio Chagas Chaves de Oliveira Junior,
  • Carlos Roberto Polaquini,
  • Luís Octávio Regasini and
  • Janaina de Cássia Orlandi Sardi

Background: Periodontal disease (PD) is a chronic inflammatory condition associated with dysbiotic biofilm, leading to the destruction of bone and periodontal ligament. Scaling and root planing (SRP) is the gold-standard treatment for PD, but some pa...

  • Review
  • Open Access
2 Citations
4,302 Views
13 Pages

Scientifically Supported Best Practices in Leachable Screening Studies for Pharmaceutical and Parenteral Drug Products

  • Arvind Singh Gusain,
  • Subhash Chandra,
  • Isaac Moura Araújo,
  • João Paulo Martins de Lima and
  • Henrique Douglas Melo Coutinho

Purpose: Pharmaceutical parenteral drug products (PDPs) and orally inhaled nasal drug products (OINDPs) are critical medications for patient care, for which the route of administration is intravenous or oral/nasal inhalation, and the drug products di...

  • Review
  • Open Access
2 Citations
2,656 Views
21 Pages

Anticancer Efficacy of Decursin: A Comprehensive Review with Mechanistic Insights

  • Tanzila Akter Eity,
  • Md. Shimul Bhuia,
  • Raihan Chowdhury,
  • Md. Arman Ali,
  • Mst Muslima Khatun,
  • Salehin Sheikh,
  • Md. Sakib Al Hasan,
  • Rubel Hasan,
  • Ivo Cavalcante Pita Neto and
  • Muhammad Torequl Islam
  • + 2 authors

Introduction: Decursin is a pyranocoumarin natural phytochemical found in the Angelica gigas Nakai herb, which shows various therapeutic properties and beneficial effects against various diseases. Objective: The aim of this study was to find the anti...

  • Article
  • Open Access
1 Citations
1,441 Views
15 Pages

Antioxidant Activity and Anxiolytic Effect of Cnidoscolus quercifolius Pohl Stem Bark Extract in Zebrafish

  • Joice Barbosa do Nascimento,
  • Johnatan Wellisson da Silva Mendes,
  • José Jonas Ferreira Viturino,
  • Maria Inácio da Silva,
  • Mariana Pereira da Silva,
  • Débora Odília Duarte Leite,
  • Emmanuel Silva Marinho,
  • Jane Eire Silva Alencar de Menezes,
  • Hélcio Silva dos Santos and
  • José Galberto Martins da Costa

Background: Cnidoscolus quercifolius, popularly known as “favela”, is used in traditional medicine to treat various conditions, such as infections and inflammations. However, its therapeutic potentials remain underexplored in scienti...

  • Article
  • Open Access
2,222 Views
11 Pages

Synergistic Antinociceptive Effects of Ketorolac and Ascorbic Acid in a Formalin-Induced Pain Model

  • Josué Vidal Espinosa-Juárez,
  • Erika Florecita Hoover-Lazo,
  • Sergio de Jesús Rubio-Trujillo,
  • Citlaly Natali de la Torre-Sosa,
  • Nereida Violeta Vega-Cabrera,
  • Josselin Carolina Corzo-Gómez,
  • Refugio Cruz-Trujillo and
  • Osmar Antonio Jaramillo-Morales

Pain is a widespread global issue and one of the most common disabling conditions in daily life. A wide range of medications are available to reduce or eliminate pain, with nonsteroidal anti-inflammatory drugs (NSAIDs) being among those most commonly...

  • Review
  • Open Access
1,852 Views
13 Pages

The aim of this review is to evaluate the therapeutic possibilities of trifluralin and other 2,6-dinitroaniline herbicides by assessing different aspects of trifluralin’s toxicology (including its mitochondrial toxicity), pharmacokinetics, and...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Future Pharmacol. - ISSN 2673-9879